Xiaomi’s Smart Band 10 debuts globally with a ceramic edition, 1.72" AMOLED display, and 21-day battery—all for just $40.

Xiaomi 15 Ultra review: In the premium segment of phones, many buyers often tend to Apple and Samsung for performance and camera capabilities. While these two brands have majorly dominated the ...

Xiaomi Pad 7 Ultra review exploring everything beyond the XRING O1 chip! We dive into display quality, productivity features, stylus support, battery life, and overall performance.

In 'Boy George & Culture Club,' Alison Ellwood charts the band’s rise to global pop domination and the frictions that pierced their bubble of success. 'Boy George & Culture Club' Review: Iconic ...

The Xiaomi Pad 7 Pro seems to have it all for a €400 tablet, so as far as a quick specs scroll goes, we have no complaints. We wish Xiaomi had considered a cellular-enabled version, though ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

Xiaomi Smart Band 10: Key Features Revealed in New Leak. The new Smart Band 10 will come with a 1.72-inch AMOLED display. It boasts a 60 Hz refresh rate and ultra-thin, symmetrical bezels.

Xiaomi Smart Band 10 leaks with 1.72-inch AMOLED display, HyperOS 2.0, ... It will run on Xiaomi’s latest HyperOS 2.0 and sync health and fitness data through the Mi Fitness app.

Xiaomi Smart Band wearables are among the most popular fitness trackers in the world. That’s largely because they offer plenty of features at an affordable price. It looks like the Smart Band 10 ...

Christian Parker and company’s Back At Home is a natural extension of these same musicians’ previous–and equally unaffected–tributes to the Byrds. 2023’s Sweethearts – A Tribute to the Byrds’ ...

Xiaomi Smart Band 10 in black The device will support more than 150 sports modes and will run HyperOS 2.0. It sports an accelerometer, gyroscope, electronic compass, PPG sensor, and an ambient ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...